MicroBioChips signed an European Sales Agreement with CapitalBio, China.

MicroBiochips is the French biotechnology company dedicated to protein&antibody biochips services and products.
MicroBioChips, the leader in protein and antibody microarrays based in France, and CapitalBio Corporation a leading total healthcare solutions provider based in Beijing, China today announced that they have entered into a European Sales Agreement. MicroBioChips will serve as CapitalBio´s major global distributor in DNA, Tissue microarrays and associated equipment. This agreement will permit MicroBioChips to propose to customers a full range in microarrays: DNA, Tissue, Proteins/antibody and associated equipment.

About CapitalBio
CapitalBio Corporation is located in Beijing and is China’s leading developer and marketer of diagnostic biochips, microarray related instruments and microarray services. The company, founded in 2000, currently has nearly 400 employees and is closely linked to the National Engineering Research Centre for Beijing Biochip Technology.
To obtain more information about CapitalBio products and services visit CapitaBio website.